Back to News
Market Impact: 0.5

Core-Main stock hits 52-week high at $59.35 amid robust growth

CNMGSBCSTFCJPM
Company FundamentalsCorporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsCapital Returns (Dividends / Buybacks)Artificial IntelligenceMarket Technicals & Flows
Core-Main stock hits 52-week high at $59.35 amid robust growth

Core & Main (CNM) reached a new 52-week high of $59.35, reflecting a 24.73% increase over the past year amid positive investor sentiment. The rise follows the company's Q4 adjusted EBITDA aligning with estimates and projected FY25 revenues slightly above expectations, leading to varied analyst reactions: RBC Capital maintained an Outperform rating with a $60 target, while Goldman Sachs reduced its target to $56 with a Neutral rating. Despite management forecasting growth in EBITDA and revenue for 2025, analyst price targets range widely, indicating a cautiously optimistic outlook.

Analysis

Core & Main Inc. (CNM) has demonstrated strong market performance, achieving a new 52-week high of $59.35, which represents a 24.73% increase over the past year, indicative of heightened investor confidence. This rally is contextualized by the company's recent financial disclosures, where fourth-quarter adjusted EBITDA reached $179 million, meeting consensus estimates, and fiscal year 2025 revenue guidance was set between $7.6 billion and $7.8 billion, slightly surpassing some analyst forecasts. Management anticipates growth in both EBITDA and revenue for 2025, citing stable pricing and end markets. However, analyst sentiment presents a mixed picture: RBC Capital maintains an Outperform rating with a $60 target, while Goldman Sachs reduced its target to $56 with a Neutral rating, though noting potential for margin improvement. Barclays remains Overweight with a $65 target, encouraged by stable gross margins and a positive revenue outlook. Conversely, Truist Securities holds a Hold rating with a $56 target, interpreting guidance as modest growth with flat pricing, and JPMorgan reiterated an Overweight rating with a $54 target, focusing on sales growth and cash flow. The wide dispersion in analyst price targets, ranging from $40 to $77, alongside strategic actions like stock repurchases and management changes, points towards a cautiously optimistic yet uncertain outlook for the company.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.